B Vogelman
Overview
Explore the profile of B Vogelman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
705
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gudmundsson S, Vogelman B, Craig W
J Antimicrob Chemother
. 1994 Dec;
34(6):921-30.
PMID: 7730235
Standard and clinical strains of Staphylococcus aureus, Escherichia coli and Klebsiella pneumoniae were subjected to continuous exposure to beta-lactams and aminoglycosides during the postantibiotic effect phase induced by rifampicin or...
2.
Turnidge J, Gudmundsson S, Vogelman B, Craig W
J Antimicrob Chemother
. 1994 Jul;
34(1):83-92.
PMID: 7961219
A total of ten strains of Candida spp. and Cryptococcus neoformans were examined for the presence of the postantibiotic effect (PAE) after 0.5-2 h exposure to amphotericin B, 5-fluorocytosine, miconazole...
3.
Fantin B, Ebert S, Leggett J, Vogelman B, Craig W
J Antimicrob Chemother
. 1991 Jun;
27(6):829-36.
PMID: 1938689
A murine thigh-infection model was used to determine the effect of certain host- and drug-related factors on the duration of the in-vivo postantibiotic effect (PAE) observed with aminoglycosides against Gram-negative...
4.
Ebert S, Gockel K, Horowitz S, Weber P, Vogelman B, Graziano F
Wis Med J
. 1991 Apr;
90(4):161-5.
PMID: 1675028
Zidovudine is the only anti-retroviral drug approved by the FDA for treatment of HIV infection. We have examined the clinical and laboratory efficacy of this drug for 4 years in...
5.
Gockel K, Vogelman B, Handy W, Graziano F
Wis Med J
. 1990 Nov;
89(11):633-4.
PMID: 2260329
No abstract available.
6.
Leggett J, Fantin B, Ebert S, Totsuka K, Vogelman B, Calame W, et al.
J Infect Dis
. 1989 Feb;
159(2):281-92.
PMID: 2644371
Animal studies that compare antibiotics have used only a limited number of doses administered at intervals chosen without regard for their pharmacodynamic effects of pharmacokinetic profiles. We compared the relative...
7.
Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model
Vogelman B, Gudmundsson S, Leggett J, Turnidge J, Ebert S, Craig W
J Infect Dis
. 1988 Oct;
158(4):831-47.
PMID: 3139779
Current antimicrobial dosing regimens are designed to maintain active drug levels for most of the dosing interval and are based on 40-y-old observations. With use of numerous multiple-dosing regimens in...
8.
Ebert S, Leggett J, Vogelman B, Craig W
J Infect Dis
. 1988 Jul;
158(1):200-2.
PMID: 3392413
No abstract available.
9.
Schleupner C, ANTHONY W, Tan J, FILE T, Lifland P, Craig W, et al.
Arch Intern Med
. 1988 Feb;
148(2):343-8.
PMID: 3277562
Cefuroxime axetil was compared with cefaclor for the therapy for lower respiratory tract infections. Sixty-one patients were randomized to receive the following drug dosages: (1) cefuroxime axetil, 250 mg orally...
10.
Vogelman B, Gudmundsson S, Turnidge J, Leggett J, Craig W
J Infect Dis
. 1988 Feb;
157(2):287-98.
PMID: 3121761
The postantibiotic effect (PAE) is the suppression of bacterial growth that persists after limited exposure of organisms to antimicrobial agents. We demonstrated and standardized the in vivo PAE in a...